SCHEMBL7765239

SCHEMBL7765239

O=C(O)c1ccc2c(c1)CCCS2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
KDM4E B2RXH2 4/20 0.49
MAPT P10636 4/20 0.49
SRD5A2 P31213 5/20 0.44
SRD5A1 P18405 4/20 0.44
HTT P42858 1/20 0.43
KDM1A O60341 2/20 0.42
LMNA P02545 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
POLB P06746 2/20 0.40
BLM P54132 1/20 0.40
GRM1 Q13255 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 2/20 0.39
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9143002 0.93 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL7759522 0.89 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL30059020 0.86 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL7548043 0.86 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL24124204 0.85 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL4694745 0.85 MAPT (0.47) ALDH1A1KDM4EMAPTLMNAMEN1
SCHEMBL8460319 0.84 MEN1 (0.52) ALDH1A1KDM4EMAPTHTTMEN1
SCHEMBL8102062 0.83 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTHTTTDP1
SCHEMBL23705035 0.81 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTSRD5A2SRD5A1
SCHEMBL10693463 0.81 ATM (0.42) ALDH1A1KDM4EMAPTHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010014745-A1 PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN DOEHNER JR ROBERT FRANCIS (US) 2001-08-16 US claimed
EP-0915092-B1 Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein BASF AG (DE) 2001-06-13 EP claimed
US-6008402-A REACTING CYCLOHEXADIENECARBOXYLATE-4-ONE COMPOUND WITH A BETA MERCAPTOPROPIONIC ACID TO GIVE THIOENOL, CYCLODEHYDRATING THE THIOENOL AMERICAN CYANAMID COMPANY (US) 1999-12-28 US claimed
EP-0915092-A1 Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein American Cyanamid Company (US) 1999-05-12 EP claimed
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-08-03 US disclosed
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-08-03 US disclosed
WO-2021257544-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2021-12-23 WO disclosed
CN-1326838-C Benzo[d]azepine derivatives for the treatment of neurological disorders GLAXO GROUP LTD (GB) 2007-07-18 CN disclosed
CN-1496987-A Pyrazole derivatives ������������ʽ���� 2004-05-19 CN disclosed
CN-1142930-C Pyrazole derivatives ������������ʽ���� 2004-03-24 CN disclosed
CN-1077106-C Pyrazole derivatives IDEMITSU KOSAN CO (JP) 2002-01-02 CN disclosed
CN-1312248-A Pyrazole derivatives IDEMITSU KOSAN CO (JP) 2001-09-12 CN disclosed
JP-2001163881-A METHOD FOR PRODUCING THIOCHROMAN-6-CARBOXYLIC ACID DERIVATIVE OR DIHYDROBENZO[b]THIOPHENE-5-CARBOXYLIC ACID DERIVATIVE IDEMITSU KOSAN CO LTD 2001-06-19 JP disclosed
JP-2001163880-A METHOD FOR PRODUCING THIOCHROMAN-6-CARBOXYLIC ACID DERIVATIVE OR DIHYDROBENZO[b]THIOPHENE-5-CARBOXYLIC ACID DERIVATIVE IDEMITSU KOSAN CO LTD 2001-06-19 JP disclosed
WO-2001040176-A1 SULFIDE COMPOUND AND PROCESSES FOR PRODUCING THIOCHROMAN DERIVATIVE AND DIHYDROBENZ[B]THIOPHENE DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2001-06-07 WO disclosed
CN-1285830-A Pyridylpyrrole derivatives SANKYO CO (JP) 2001-02-28 CN disclosed
US-6159904-A Pyrazole derivatives IDEMITSU KOSAN CO., LTD. (JP) 2000-12-12 US disclosed
EP-1031572-A1 PYRIDYLPYRROLE DERIVATIVES Sankyo Company Limited (JP) 2000-08-30 EP disclosed
EP-0970956-A1 PYRAZOLE DERIVATIVES IDEMITSU KOSAN COMPANY LIMITED (JP) 2000-01-12 EP disclosed
CN-1181080-A Pyrazole derivatives IDEMITSU KOSAN CO (JP) 1998-05-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242496-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA BCL6, SOX18, BCL3 ALDH1A1 2654/4885KDM4E 204/4885MAPT 4492/4885
US-20010014745-A1 PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN DDT, CYP4X1, CYP2B6 ALDH1A1 119/4885KDM4E 1320/4885MAPT 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.